April 27, 2024 07:34 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
6.1 magnitude earthquake hits Taiwan, no immediate damages reported | Arjuna awardee CRPF officer found guilty of sexual harassment charges, faces dismissal | Opposition's dreams shattered: PM Modi on Supreme Court's VVPAT verdict | Supreme Court rejects plea seeking 100 pct votes verification on EVMs, rules out returning to ballot papers | Voting concludes in 88 constituencies with 61% turnout by 5 pm
HSI India and PFA welcome India decision to end repeat animal testing of drugs

HSI India and PFA welcome India decision to end repeat animal testing of drugs

India Blooms News Service | | 18 Mar 2016, 01:17 pm
New Delhi, Mar 18 (Just Earth News/IBNS) Leading animal protection organizations Human Society International (HSI) and People for Animal (PFA) on Friday lauded the move by the Union Ministry of Health and Family banning repeat animal testing of new drugs already tested abroad, thus sparing cruelty to thousands of animals.

The ban falls under amendment Schedule Y, in the Appendix I, under item 4 where after sub-item 4.8, the following note shall be inserted - “Where the data on animal toxicity as per the specifications of Appendix III has been submitted and the same has been considered by the regulatory authority of the country which had earlier approved the drug, the animal toxicity studies shall not be required to be conducted in India except in cases where there are specific concerns recorded in writing.”

 Humane Society International/India and People for Animals welcomed the decision.

Gauri Maulekhi, HSI/India consultant and a trustee at People for Animals, said, “We welcome and laud this move by the Health Ministry. The new amendment will not only save thousands of animals every year from being subjected to redundant animal testing, it also marks the beginning of a potential new era of sophisticated animal testing alternatives in India.

"We look forward to continuing our association with the Ministry to ensure that use of validated alternatives is encouraged as the Drug Technical Advisory Board has recommended.”

This move comes after Union Minister of Women & Child Development,  Maneka Sanjay Gandhi, wrote to the Ministry regarding the practice. The Investigational New Drug Committee, which considered the matter before the Drug Technical Advisory Board, states that if the drugs were tested elsewhere under Good Laboratory Practice conditions and align with India’s regulatory requirement, no further toxicity testing shall be required. Both committees also are encouraging the use of internationally accepted non-animal alternatives where available.

India has been a full adherent to the Organization for Economic Cooperation and Development decision regarding Mutual Acceptance of Data since 2011. As a consequence, the data generated by Indian Good Laboratory Practice laboratories must be accepted in all the OECD member countries, and vice-versa. The OECD estimates that adherence to MAD saves more than €150 million and scores of animals per year by avoiding needlessly duplicative testing. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.